Overview

This comprehensive colour atlas provides a state-of-the-art view of Single Photon Emission Computerised Tomography (SPECT) in relation to its application in the fields of nuclear medicine and psychiatry. The broad range of topics covered by experts in the fields of nuclear medicine, neurology and psychiatry from all over the world, reflects the most recent evolution in functional neuroimaging with clinical neuropsychiatric sciences. The book is organised with respect to clinical indication, which implies that whenever possible methodological problems related to clinical indication are categorised under the relevant topic. It is designed to stimulate discussion of some issues of paramount importance for the present and future development of this interdisciplinary modality for the study of patients with diseases of the central nervous system. This textbook is an important tool to all nuclear physicians, neurologists and psychiatrists and will serve as a guide towards the optimal application of SPECT in diagnosis, study of pathophysiology and therapeutic follow-up in neuropsychiatric illnesses.

Full Product Details

Author:   P P De Deyn ,  R A Dierckx ,  A Alavi ,  B A Pickut
Publisher:   John Libbey & Co
Imprint:   John Libbey & Co Ltd
Dimensions:   Width: 25.50cm , Height: 3.30cm , Length: 19.50cm
Weight:   1.412kg
ISBN:  

9780861965427

ISBN 10:   0861965426
Pages:   568
Publication Date:   01 January 1997
Audience:   College/higher education ,  Professional and scholarly ,  Postgraduate, Research & Scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Available To Order  
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Part 1 Dementia: the importance of single photon emission computed tomography (SPECT, cerebral blood flow imaging to accurate diagnosis in histologically confirmed dementia; SPECT and magnetic resonance imaging (MRI) in vascular dementia and Alzheimer's disease; discriminative use of SPECT in dementia with frontal lobe features versus SDAT; comparison of cholinergic neuroreceptor SPECT (I-123 iododexetimide) with Tc-99m HMPAO in the early diagnosis of Alzheimer's disease (AD); Lewy body dementia - can it be distinguished from Alzheimer's disease during life by SPECT? Part 2 Neuropsychology: use of HMPAO to invesigate memory function in patients with amnesia. Part 3 Psychiatry: in vivo receptor measurement by single photon emission tomography (SPECT) - applications to neuropharmacology; SPECT imaging in mood disorders; reduced frontal cerebral blood flow in drug-free obsessive-compulsive disorder (OCD) - preliminary data of a SPECT study; experimental neuroactivation with SPECT in schizophrenics. Part 4 Movement disorders: SPECT imaging of he dopamine transporter - potential diagnostic test for Parkinson's disease; SPECT of the dopaminergic system in Parkinsonian syndromes; brain-SPECT I-123 distribution analysis to differentiate patients with idiopathic Parkinson syndrome, multiple-system atrophy and progressive supranuclear palsy; the application of [I-123]b-CIT and SPECT in the diagnosis of movement disorder; quantification of the dopaminergic nerve cell loss in Parkinson's disease and ageing [I-123]b-CIT and SPECT. Part 5 Epilepsy. Part 6 Paediatrics. Part 7 Cerbrovascular disorders. Part 8 Tumour. Part 9 Trauma capitis. Part 10 Specific application. Part 11 Techniques. (Part contents)

Reviews

Author Information

Tab Content 6

Author Website:  

Countries Available

All regions